Tahor and blood creatine phosphokinase increased Patient Reports March 19, 2010

Tahor Side Effects Report #4831545-8
Tahor side effect was reported by a Physician from FRANCE on Nov 10, 2005. Female patient, 47 years of age, weighting 211.6 lb, was diagnosed with type iia hyperlipidaemia, ill-defined disorder, breast cancer  and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood glucose increased, blood pressure decreased, breast cancer , condition aggravated, conduction disorder, hepatic encephalopathy, hepatic failure. Tahor dosage: 10 MG (10 MG, 1 IN 1 D) ORAL. During the same period patient was treated with INIPOMP, LYTOS, ANASTROZOLE, PRIMALAN, ENDOTELON. Patient was hospitalized. Patient died on 03/16/2005.

Tahor Side Effects Report #5679402-1
Tahor side effect was reported by a Physician from FRANCE on Mar 14, 2008. Female patient, weighting 127.9 lb, was diagnosed with type iia hyperlipidaemia, hypertension and was treated with Tahor. After drug was administered, patient experienced the following side effects: arthropathy, blood creatine phosphokinase increased, leukocytosis, pain in extremity. Tahor dosage: unknown. During the same period patient was treated with COTAREG, ZANIDIP. Patient was hospitalized. Patient recovered.

Tahor Side Effects Report #5888401-6
Tahor side effect was reported by a Physician from FRANCE on Sept 08, 2008. Male patient, 57 years of age, was diagnosed with stent placement and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cytolytic hepatitis, muscle spasms, myalgia, rhabdomyolysis, tetany. Tahor dosage: unknown. During the same period patient was treated with ASPIRIN, ATACAND, CELECTOL. Patient recovered.

Tahor Side Effects Report #5896075-3
Tahor side effect was reported by a Physician from FRANCE on Sept 08, 2008. Male patient, 57 years of age, was diagnosed with stent placement and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cytolytic hepatitis, muscle spasms, myalgia, rhabdomyolysis, tetany. Tahor dosage: unknown. During the same period patient was treated with KARDEGIC, ATACAND, CELECTOL. Patient recovered.


Tahor Side Effects Report #5915808-0
Tahor side effect was reported by a Physician from FRANCE on Oct 02, 2008. Male patient, weighting 216.1 lb, was diagnosed with stent placement, infarction and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cytolytic hepatitis, muscle spasms, myalgia, rhabdomyolysis, tetany. Tahor dosage: unknown. During the same period patient was treated with KARDEGIC, ATACAND, CELECTOL. Patient recovered.

Tahor Side Effects Report #5207876-9
Tahor side effect was reported by a Physician from FRANCE on Jan 05, 2007. Female patient, 76 years of age, was diagnosed with myocardial ischaemia and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, myalgia. Tahor dosage: unknown. During the same period patient was treated with IRINOTECAN, CETUXIMAB, ATENOLOL, IDEOS, DAFLON, ZANIDIP, LASIX, PRACTON. Patient recovered.

Tahor Side Effects Report #5570038-X
Tahor side effect was reported by a Physician from FRANCE on Dec 10, 2007. Female patient, 81 years of age, was diagnosed with myocardial infarction, angioplasty  and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, rhabdomyolysis. Tahor dosage: unknown. During the same period patient was treated with FLUINDIONE, CARDENSIEL, PLAVIX, OMEPRAZOLE. Patient was hospitalized. Patient died on 11/01/2007.

Tahor Side Effects Report #5942407-7
Tahor side effect was reported by a Physician from FRANCE on Oct 07, 2008. Male patient, 48 years of age, was diagnosed with myocardial infarction and was treated with Tahor. After drug was administered, patient experienced the following side effects: amyotrophy, blood creatine phosphokinase increased, muscle spasms, myalgia. Tahor dosage: unknown. During the same period patient was treated with EZETIMIBE. Patient recovered.

Tahor Side Effects Report #5679398-2
Tahor side effect was reported by a Physician from FRANCE on Mar 14, 2008. Male patient, weighting 169.8 lb, was diagnosed with myocardial infarction, coronary artery bypass  and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscular weakness, myalgia, neuromyopathy. Tahor dosage: unknown. During the same period patient was treated with ATENOLOL, TRIATEC, KARDEGIC. Patient recovered.


Tahor Side Effects Report #5812416-7
Tahor side effect was reported by a Physician from FRANCE on May 28, 2008. Male patient, weighting 169.8 lb, was diagnosed with myocardial infarction, coronary artery bypass  and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, hypothyroidism, muscular weakness, neuromyopathy. Tahor dosage: unknown. During the same period patient was treated with ATENOLOL, RAMIPRIL, KARDEGIC. Patient recovered.

Tahor Side Effects Report #5293799-6
Tahor side effect was reported by a Physician from FRANCE on Mar 30, 2007. Female patient, 65 years of age, was diagnosed with ischaemic heart disease prophylaxis and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cardiac disorder, renal failure, transaminases increased. Tahor dosage: unknown. During the same period patient was treated with CHLOROTHIAZIDE. Patient died.

Tahor Side Effects Report #4596828-8
Tahor side effect was reported by a Physician from on Feb 16, 2005. Male patient, 81 years of age, was diagnosed with ill-defined disorder and was treated with Tahor. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, bronchial infection, myalgia, renal failure. Tahor dosage: 10 MG (1 IN 1 D), ORAL. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, ATENOLOL, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.

Tahor Side Effects Report #4672760-6
Tahor side effect was reported by a Physician from on May 16, 2005. Female patient, 70 years of age, was diagnosed with ill-defined disorder, bronchitis  and was treated with Tahor. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, asthenia, biopsy muscle abnormal, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, bronchitis , c-reactive protein increased, dermatomyositis, dilatation ventricular. Tahor dosage: unknown. During the same period patient was treated with KETEK, ACTONEL. Patient was hospitalized and became disabled. Patient recovered.

Tahor Side Effects Report #4676991-0
Tahor side effect was reported by a Physician from on May 16, 2005. Female patient, 70 years of age, was diagnosed with ill-defined disorder, bronchitis  and was treated with Tahor. After drug was administered, patient experienced the following side effects: asthenia, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, bronchitis , dermatomyositis, dyspnoea exertional, mobility decreased, motor dysfunction, muscle disorder . Tahor dosage: unknown. During the same period patient was treated with KETEK, ACTONEL. Patient was hospitalized. Patient recovered.


Tahor Side Effects Report #4693879-X
Tahor side effect was reported by a Physician from on June 14, 2005. Male patient, 52 years of age, was diagnosed with ill-defined disorder and was treated with Tahor. After drug was administered, patient experienced the following side effects: acute coronary syndrome, blood creatine phosphokinase increased, myocardial infarction, post procedural complication. Tahor dosage: 40 MG. Patient recovered.

Tahor Side Effects Report #4643146-5
Tahor side effect was reported by a Pharmacist from on Mar 23, 2005. Female patient, 50 years of age, was diagnosed with ill-defined disorder and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, hepatitis fulminant, metastases to liver. Tahor dosage: unknown. Patient was hospitalized. Patient died on 03/21/2005.

Tahor Side Effects Report #4634597-3
Tahor side effect was reported by a Physician from on Apr 06, 2005. Male patient, 44 years of age, was diagnosed with hyperlipidaemia and was treated with Tahor. After drug was administered, patient experienced the following side effects: amyotrophy, anuria, ascites, aspartate aminotransferase increased, blood creatine phosphokinase increased, dialysis , hepatic cirrhosis, hepatorenal syndrome, hyperkalaemia. Tahor dosage: 40 MG (40 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SUCRALFATE, TAUROURSODESOXYCHOLIC ACID, PROPRANOLOL HYDROCHLORIDE. Patient was hospitalized. Patient died on 02/10/2005.

Tahor Side Effects Report #4559544-4
Tahor side effect was reported by a Physician from on Jan 10, 2005. Male patient, 77 years of age, was diagnosed with hypercholesterolaemia and was treated with Tahor. After drug was administered, patient experienced the following side effects: abdominal pain , blood creatine phosphokinase increased, blood lactate dehydrogenase increased, c-reactive protein increased, diverticulitis, electrocardiogram abnormal, myoglobin blood increased, pyrexia, rhabdomyolysis. Tahor dosage: 10 MG (1 IN 1 D), ORAL. During the same period patient was treated with ACARBOSE, LACTOBACILLUS BIFIDUS, OMEPRAZOLE, HEXAQUINE, DILTIAZEM HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Tahor Side Effects Report #4551084-1
Tahor side effect was reported by a Physician from on Nov 23, 2004. Male patient, 65 years of age, weighting 194.0 lb, was diagnosed with hypercholesterolaemia and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, coronary artery occlusion, myocardial infarction. Tahor dosage: 10 MG (10 MG, 1 IN 1 D). Patient was hospitalized. Patient recovered.


Tahor Side Effects Report #5432279-1
Tahor side effect was reported by a Physician from FRANCE on Aug 22, 2007. Male patient, 53 years of age, was diagnosed with hypercholesterolaemia and was treated with Tahor. After drug was administered, patient experienced the following side effects: amyotrophy, blood creatine phosphokinase increased, muscle spasms, muscular weakness, myalgia, weight decreased. Tahor dosage: unknown. Patient recovered.

Tahor Side Effects Report #5229773-5
Tahor side effect was reported by a Physician from FRANCE on Jan 18, 2007. Male patient, weighting 160.9 lb, was diagnosed with hypercholesterolaemia and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle spasms, muscle twitching, myalgia, myositis , nerve root lesion. Tahor dosage: unknown. During the same period patient was treated with NEXIUM, FINASTERIDE, ESOMEPRAZOLE MAGNESIUM. Patient recovered.

Tahor Side Effects Report #5331475-1
Tahor side effect was reported by a Physician from FRANCE on May 10, 2007. Male patient, weighting 160.9 lb, was diagnosed with hypercholesterolaemia and was treated with Tahor. After drug was administered, patient experienced the following side effects: amyotrophic lateral sclerosis , atrophy, blood creatine phosphokinase increased, muscle spasms, muscle twitching, muscular weakness, myalgia, myositis , nerve root lesion. Tahor dosage: unknown. During the same period patient was treated with NEXIUM, FINASTERIDE, ESOMEPRAZOLE MAGNESIUM. Patient recovered.

Tahor Side Effects Report #5324489-9
Tahor side effect was reported by a Physician from FRANCE on May 04, 2007. Male patient, weighting 132.3 lb, was diagnosed with dyslipidaemia and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood glucose increased, cytolytic hepatitis. Tahor dosage: unknown. Patient recovered.

Tahor Side Effects Report #5575128-3
Tahor side effect was reported by a Physician from FRANCE on Dec 17, 2007. Female patient, 74 years of age, was diagnosed with cerebrovascular accident and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, liver disorder, rhabdomyolysis, transaminases increased. Tahor dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.


Tahor Side Effects Report #5674813-2
Tahor side effect was reported by a Physician from FRANCE on Mar 11, 2008. Female patient, weighting 167.6 lb, was diagnosed with cerebrovascular accident and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cytolytic hepatitis, liver disorder, rhabdomyolysis, transaminases increased. Tahor dosage: unknown. During the same period patient was treated with INIPOMP, ASPEGIC, XANAX, SEROPRAM, HEPTAMINOL HYDROCHLORIDE. Patient was hospitalized and became disabled. Patient recovered.

Tahor Side Effects Report #5306694-0
Tahor side effect was reported by a Physician from FRANCE on Apr 13, 2007. Male patient, 55 years of age, was diagnosed with carotid artery occlusion and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle spasms, myalgia. Tahor dosage: unknown. Patient recovered.

Tahor Side Effects Report #5344468-5
Tahor side effect was reported by a Physician from FRANCE on May 23, 2007. Male patient, weighting 167.6 lb, was diagnosed with carotid artery occlusion, dyslipidaemia and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, hernia , muscle spasms, myalgia. Tahor dosage: unknown. During the same period patient was treated with KARVEA HCT, ASPIRIN, CLOPIDOGREL, ULTRACET. Patient recovered.

Tahor Side Effects Report #5614277-8
Tahor side effect was reported by a Physician from FRANCE on Jan 30, 2008. Male patient, weighting 198.4 lb, was diagnosed with blood cholesterol and was treated with Tahor. After drug was administered, patient experienced the following side effects: abasia, abdominal pain upper, blood creatine phosphokinase increased, muscle spasms, oedema peripheral, transaminases increased, visual acuity reduced. Tahor dosage: unknown. During the same period patient was treated with NEXIUM, EZETROL, LASILIX, ALLOPURINOL, LOSARTAN POTASSIUM, FELODIPINE, GAVISCON, LACTULOSE. Patient recovered.

Tahor Side Effects Report #5273174-0
Tahor side effect was reported by a Physician from FRANCE on Mar 12, 2007. Female patient, 88 years of age, was diagnosed with acute coronary syndrome and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, dehydration, renal failure, rhabdomyolysis. Tahor dosage: unknown. Patient died.


Tahor Side Effects Report #5974847-4
Tahor side effect was reported by a Physician from FRANCE on Nov 27, 2008. Male patient, 58 years of age, was diagnosed with acute coronary syndrome, diabetic foot infection and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle disorder , polymyositis, speech disorder. Tahor dosage: unknown. During the same period patient was treated with FUCIDINE CAP. Patient recovered.

Tahor Side Effects Report #4960827-4
Tahor side effect was reported by a Physician from FRANCE on Mar 16, 2006. Male patient, 53 years of age, was diagnosed with acute coronary syndrome and was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle disorder . Tahor dosage: 80 MG (80 MG, 1 IN 1 D). During the same period patient was treated with CLOPIDOGREL. Patient recovered.

Tahor Side Effects Report #5296777-6
Tahor side effect was reported by a Physician from FRANCE on Apr 02, 2007. Male patient, 82 years of age, was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, coronary artery restenosis, coronary artery stenosis, low density lipoprotein increased. Tahor dosage: unknown. During the same period patient was treated with CRESTOR. Patient was hospitalized. Patient recovered.

Tahor Side Effects Report #5524366-4
Tahor side effect was reported by a Consumer or non-health professional from FRANCE on Nov 13, 2007. Male patient, 65 years of age, was treated with Tahor. After drug was administered, patient experienced the following side effects: abasia, abdominal pain upper, blood creatine phosphokinase increased, muscle spasms, oedema peripheral, transaminases increased, visual acuity reduced. Tahor dosage: unknown. Patient recovered.

Tahor Side Effects Report #5115435-1
Tahor side effect was reported by a Physician from FRANCE on Sept 15, 2006. Male patient, 60 years of age, was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood potassium decreased, oedema peripheral, paraesthesia, poisoning . Tahor dosage: 40 MG. During the same period patient was treated with HERBAL PREPARATION, ASPIRIN. Patient was hospitalized. Patient recovered.


Tahor Side Effects Report #5443783-4
Tahor side effect was reported by a Physician from FRANCE on Aug 27, 2007. Male patient, 60 years of age, was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cholestasis, gamma-glutamyltransferase increased. Tahor dosage: unknown. Patient was hospitalized. Patient recovered.

Tahor Side Effects Report #5895044-7
Tahor side effect was reported by a Physician from FRANCE on Sept 16, 2008. Male patient, 60 years of age, was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, epilepsy . Tahor dosage: unknown. Patient was hospitalized. Patient recovered.

Tahor Side Effects Report #5900641-6
Tahor side effect was reported by a Physician from FRANCE on Sept 19, 2008. Male patient, 60 years of age, was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, epilepsy . Tahor dosage: unknown. Patient was hospitalized. Patient recovered.

Tahor Side Effects Report #5578426-2
Tahor side effect was reported by a Physician from FRANCE on Dec 21, 2007. Male patient, 55 years of age, was treated with Tahor. After drug was administered, patient experienced the following side effects: aldolase increased, blood creatine phosphokinase increased, posture abnormal, rhabdomyolysis. Tahor dosage: unknown. During the same period patient was treated with FLUINDIONE. Patient recovered.

Tahor Side Effects Report #5888483-1
Tahor side effect was reported by a Physician from FRANCE on Sept 10, 2008. Female patient, 53 years of age, was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, pain , paraesthesia, rhabdomyolysis. Tahor dosage: unknown. Patient recovered.


Tahor Side Effects Report #5093325-0
Tahor side effect was reported by a Physician from FRANCE on Aug 16, 2006. Female patient, 52 years of age, was treated with Tahor. After drug was administered, patient experienced the following side effects: asthenia, blood creatine phosphokinase increased, dyspnoea, fatigue, myalgia, thyroiditis. Tahor dosage: 10 MG (10 MG, 1 IN 1 D). During the same period patient was treated with LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Tahor Side Effects Report #5093356-0
Tahor side effect was reported by a Physician from FRANCE on Aug 16, 2006. Male patient, 51 years of age, was treated with Tahor. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatine phosphokinase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood triglycerides increased, cholestasis. Tahor dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DALACIN, PLAVIX, RAMIPRIL, SECTRAL, OMEPRAZOLE, LEXOMIL, BACTRIM, ACENOCOUMAROL. Patient was hospitalized. Patient recovered.

Tahor Side Effects Report #5050689-1
Tahor side effect was reported by a Pharmacist from FRANCE on June 27, 2006. Female patient was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, rebound effect. Tahor dosage: (20 MG). Patient recovered.

Tahor Side Effects Report #5450330-X
Tahor side effect was reported by a Physician from FRANCE on Sept 04, 2007. Female patient, weighting 163.1 lb, was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, muscle disorder , rhabdomyolysis. Tahor dosage: unknown. During the same period patient was treated with TAREG, LEVOTHYROX, ZOLPIDEM TARTRATE. Patient recovered.

Tahor Side Effects Report #5531003-1
Tahor side effect was reported by a Physician from FRANCE on Nov 21, 2007. Female patient, weighting 132.3 lb, was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, brain natriuretic peptide increased, low density lipoprotein increased, myalgia, transaminases increased. Tahor dosage: unknown. During the same period patient was treated with ACEBUTOLOL HYDROCHLORIDE, KARDEGIC, LEVOTHYROXINE, OMEPRAZOLE, LEXOMIL. Patient recovered.

Tahor Side Effects Report #5848878-9
Tahor side effect was reported by a Health Professional from FRANCE on Aug 08, 2008. Male patient was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, hepatitis , renal failure. Tahor dosage: DAILY DOSE:20MG. During the same period patient was treated with AUGMENTIN, ARICEPT, ASPIRIN, NEBIVOLOL, COVERSYL, TRINITRINE, LYTOS. Patient was hospitalized. Patient recovered.

Tahor Side Effects Report #6119760-7
Tahor side effect was reported by a Physician from FRANCE on Mar 13, 2009. Female patient was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, food aversion, infection , inflammation, muscular weakness, myalgia, nausea , transaminases increased, white blood cell count increased. Tahor dosage: 80 MG, 1X/DAY. Patient was hospitalized. Patient recovered.

Tahor Side Effects Report #6126790-8
Tahor side effect was reported by a Physician from FRANCE on Mar 10, 2009. Female patient was treated with Tahor. After drug was administered, patient experienced the following side effects: acute coronary syndrome, blood creatine phosphokinase increased, transaminases increased. Tahor dosage: 80 MG, UNK. Patient was hospitalized. Patient recovered.

Tahor Side Effects Report #6134899-8
Tahor side effect was reported by a Physician from FRANCE on Mar 13, 2009. Female patient was treated with Tahor. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, inflammation, muscular weakness, myalgia, nausea , transaminases increased, white blood cell count increased. Tahor dosage: 80 MG, 1X/DAY. Patient was hospitalized. Patient recovered.